Applied Therapeutics Stock Price, News & Analysis
APLT
NASDAQ
Company Description
Welcome to the overview page for Applied Therapeutics (APLT), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$0.0961
-1.03%
0.00
Last updated: December 31, 2025 at 09:12
-88.09 %
Performance 1 year
$15.2M
144.3M
Latest News
SEC Filings
Insider Radar
Net Sellers
90-Day Summary
0
Shares Bought
43,000
Shares Sold
1
Transactions
Most Recent Transaction
Kanter Stacy J.
(Director)
sold
43,000 shares
@ $0.11
on Dec 16, 2025
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
$122,000
Revenue (TTM)
-$68,591,000
Net Income (TTM)
-$0.48
-$23,330,000
Operating Cash Flow
-56,222.13%
-24,379.51%
Upcoming Events
JAN
01
January 1, 2026 - March 31, 2026
Corporate
Tender offer close
Expected close in Q1 2026; merger has no financing condition; includes CVR payout structure.
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Applied Therapeutics (APLT)?
The current stock price of Applied Therapeutics (APLT) is $0.0971 as of December 30, 2025.
What is the market cap of Applied Therapeutics (APLT)?
The market cap of Applied Therapeutics (APLT) is approximately 15.2M. Learn more about what market capitalization means .
What is the revenue (TTM) of Applied Therapeutics (APLT) stock?
The trailing twelve months (TTM) revenue of Applied Therapeutics (APLT) is $122,000.
What is the net income of Applied Therapeutics (APLT)?
The trailing twelve months (TTM) net income of Applied Therapeutics (APLT) is -$68,591,000.
What is the earnings per share (EPS) of Applied Therapeutics (APLT)?
The diluted earnings per share (EPS) of Applied Therapeutics (APLT) is -$0.48 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Applied Therapeutics (APLT)?
The operating cash flow of Applied Therapeutics (APLT) is -$23,330,000. Learn about cash flow.
What is the profit margin of Applied Therapeutics (APLT)?
The net profit margin of Applied Therapeutics (APLT) is -56,222.13%. Learn about profit margins.
What is the operating margin of Applied Therapeutics (APLT)?
The operating profit margin of Applied Therapeutics (APLT) is -24,379.51%. Learn about operating margins.
What is the current ratio of Applied Therapeutics (APLT)?
The current ratio of Applied Therapeutics (APLT) is 1.06, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Applied Therapeutics (APLT)?
The operating income of Applied Therapeutics (APLT) is -$29,743,000. Learn about operating income.